NON-VESTIBULAR SCHWANNOMA

Clinical trials for NON-VESTIBULAR SCHWANNOMA explained in plain language.

Never miss a new study

Get alerted when new NON-VESTIBULAR SCHWANNOMA trials appear

Sign up with your email to follow new studies for NON-VESTIBULAR SCHWANNOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for slowing NF2 tumor growth in groundbreaking trial

Disease control Ongoing

This study is testing two different drugs, brigatinib and neratinib, to see if they can slow or shrink tumors in people with a genetic condition called NF2-related schwannomatosis. About 100 participants with growing tumors will be assigned to receive one of the drugs. The main g…

Matched conditions: NON-VESTIBULAR SCHWANNOMA

Phase: PHASE2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

NON-VESTIBULAR SCHWANNOMA

Get alerted when new NON-VESTIBULAR SCHWANNOMA trials appear

New hope for slowing NF2 tumor growth in groundbreaking trial